David Merryman

Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without serious neurological side effects. Merryman conducted... Read More

Biomedical engineer David Merryman and Warren Center for Neuroscience Drug Discovery director Craig Lindsley have developed a new drug that treats PAH, a type of high blood pressure that affects arteries in the lungs and in the heart, without serious neurological side effects. Read More

David Merryman has discovered that targeting a protein receptor in heart cells may limit a heart attack’s acute and long-term effects. Read More

Vanderbilt’s eight newest endowed chair holders were recognized by Interim Chancellor and Provost Susan R. Wente, deans, colleagues, family members and donors Sept. 16 at the Student Life Center. Read More

A new study published by Vanderbilt mechanobiology researchers details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery – thanks to an antibody initially developed for rheumatoid arthritis.  Read More

A big-data analysis of patient records at Vanderbilt University has found a link specifically between Celebrex and heart valve calcification. Read More

Pulmonary hypertension may be treated by targeting a bone marrow cell that normally promotes the growth of new blood vessels, according to new research by David Merryman. Read More

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Read More

Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs. Read More

The 2017 class of Chancellor Faculty Fellows comprises highly accomplished, recently tenured faculty from across the university. Read More

David Merryman will study how to treat heart disease using drugs originally developed for rheumatoid arthritis and applying the lessons learned from failed weight loss drugs like Fen-Phen. Read More

Five biomedical engineering professors and an electrical engineering and computer science professor are celebrating news about newly approved or resubmitted Research Project Grants (R01) from the Nationals Institutes of Health. Read More

New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension. Read More

The mechanical forces generated by the rhythmic expansion and contraction of cardiac muscle cells play an active role in the initial stage of heart valve formation. Read More

A protein that connects cells together participates in the calcification that occurs in heart valve disease. Read More

This Week on VUCast, Vanderbilt’s online newscast: Eat more, lose weight! A Vandy nutritionist shows how it works Anger in the court! Why ticked-off judges may be better judges. See what inspires some of our professors to teach. Read More

Blocking a serotonin receptor may provide a novel therapy for heart valve disease. Read More

David Merryman, assistant professor of biomedical engineering, is among 78 of the nation's brightest young engineers selected to take part in the National Academy of Engineering's 18th annual U.S. Frontiers of Engineering symposium. Read More

Talk to people who know David Merryman best, and one adjective is heard frequently: passionate. Talk to Merryman yourself and it is easy to see why. Discussing his research, the assistant professor of biomedical engineering seems ready to leap out of his chair at any moment, perhaps to tweak the… Read More

Abdiweli Mohamed Ali (photo courtesy of Niagara University)     Abdiweli Mohamed Ali, a Vanderbilt master’s degree graduate in economics, has been named prime minister of Somalia. Michael Burcham, lecturer in management; John Howser, director of medical center… Read More